世界中医药

目的：探讨社区获得性肺炎采用疏风解毒胶囊治疗的疗效。方法：选择2013年1月至2015年3月期间在我院治疗的128例社区获得性肺炎患者为对象，采用随机数字表法将所有患者随机分为研究组与对照组。研究组患者采用头孢呋辛钠静脉滴注，1.5 g/d，连续1周，同时患者口服疏风解毒胶囊，每次4粒、3次/d，连续1周；对照组患者仅予以头孢呋辛钠静脉滴注，1.5 g/d，连续1周。观察、比较、分析2组患者治疗前后的症状与体征变化、感染性指征变化情况、患者治疗效果以及胸片DR等指标。结果：2组相比，研究组的临床症状与体征改善时间更短（P<0.05）；研究组患者的感染性指征在第3日明显改善，1周后基本消失，而对照组在第七天才观察到明显的改善（P<0.01）；研究组患者的治疗总有效率为95.3%，对照组仅为84.4%（P<0.05）。结论：疏风解毒胶囊能够加速社区获得性肺炎的症状改善，有助于提高获得性肺炎的治愈率。

English Summary:

To investigate the effect of treatment of community acquired pneumonia by using Shufeng Jiedu Capsule. Methods: A hundred and twenty-eight cases of community acquired pneumonia treated in the hospital from January 2013 to March 2013 were included, and equally divided into study group and control group by random digits table. Patients in the study group received intravenous infusion of cefuroxime sodium, daily 1.5 g, for a week, and oral taking Shufeng Jiedu capsule with four capsules once, three times a day, for a week. Patients in the control group were given intravenous infusion of cefuroxime sodium, daily 1.5 g, for a week. Changes in symptoms, signs, infective indicator, curative effects and Chest radiograph DR and other indicators between the two groups before and after treatment were observed, compared and analyzed. Results: The results of this study showed that the time of the study group when the clinical symptoms and signs improved after treatment was shorter (P<0.05). The obvious improvement of infective indicator for patients in the study group was significantly at the fourth days but seventh day in the control group, and patients in the study group were recovered in a week. (P<0.01). The total effective rate of the study group was 95% and that of the control group was 80% (P<0.05). Conclusion: Shufeng Jiedu Capsule may work on improvement of symptoms of community-acquired pneumonia and enhance the curative rate.

查看全文查看/发表评论下载PDF阅读器